Naruto, Japan

Ariumi Kawamoto

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Tomita Pharmaceutical Co., Ltd.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ariumi Kawamoto. Retrieved from https://idiyas.com/inventor/ariumi-kawamoto

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ariumi Kawamoto: Innovator in Pharmaceutical Preparations

Introduction

Ariumi Kawamoto is a notable inventor based in Naruto, Japan. He has made significant contributions to the field of pharmaceutical preparations, particularly through his innovative patent.

Latest Patents

Kawamoto holds a patent for a core particle designed for pharmaceutical preparations. This invention provides a core particle that possesses essential properties, ensuring chemical stability while limiting reactivity with the active pharmaceutical ingredient. Specifically, the core particle is made from a pharmaceutically acceptable inorganic material that is poorly soluble in water, with a pH range of 5 to 8. This advancement allows for the formation of a film containing the active pharmaceutical ingredient on the surface of the core particle.

Career Highlights

Ariumi Kawamoto is associated with Tomita Pharmaceutical Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work focuses on enhancing the effectiveness and stability of pharmaceutical preparations.

Collaborations

Kawamoto collaborates with esteemed colleagues, including Masashi Konishi and Shouichi Oonishi, to further advance research and development in his field.

Conclusion

Ariumi Kawamoto's contributions to pharmaceutical preparations through his innovative patent demonstrate his commitment to improving drug formulation and stability. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…